From: Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases
KRAS-wt
n = 63
KRAS-mut
n = 38
P-value
Total cohort
26/63 (41.3%)
23/38 (60.5%)
0.068
Synchronous metastases
15/34 (44.1%)
14/22 (63.6%)
0.180
Metachronous metastases
11/29 (37.9%)
9/16 (56.3%)
0.348